Lisa Kitasato

Amotl1 mediates sequestration of the Hippo effector Yap1 downstream of Fat4 to restrict heart growth

Chiara V. Ragni, Nicolas Diguet, Jean‐François Le Garrec et al. · Nature Communications · 2017 · 110 citations · Full text

Effects on bone metabolism markers and arterial stiffness by switching to rivaroxaban from warfarin in patients with atrial fibrillation

S Namba, Minako Yamaoka‐Tojo, Ryota Kakizaki et al. · Heart and Vessels · 2017 · 51 citations

Thrombosis, Cardiovascular Disease, Atherosclerosis +15

Rivaroxaban Inhibits Angiotensin II-Induced Activation in Cultured Mouse Cardiac Fibroblasts Through the Modulation of NF-<i>κ</i>B Pathway

Takehiro Hashikata, Minako Yamaoka‐Tojo, S Namba et al. · International Heart Journal · 2015 · 50 citations · Full text

Cardiac Muscle, Heart Failure, Immunology +19

Long-term warfarin therapy and biomarkers for osteoporosis and atherosclerosis

S Namba, Minako Yamaoka‐Tojo, Takehiro Hashikata et al. · BBA Clinical · 2015 · 42 citations · Full text

Teneligliptin improves left ventricular diastolic function and endothelial function in patients with diabetes

Takehiro Hashikata, Minako Yamaoka‐Tojo, Ryota Kakizaki et al. · Heart and Vessels · 2015 · 37 citations

Metabolic Syndrome, Hypertension, Heart Failure +14